Bod Science Ltd News

Bod Science Announces Delay in Appendix 4D Lodgement

Bod Science (ASX:BOD) said its appendix 4D, or half-year report, for the six months ended Dec. 31, 2023, will be delayed anew following a rejection by the the Australian Securities and Investments Com

MT NewswiresMar 26 05:43

BOD Science Signs Supply Agreement in Medicinal Cannabis With Green Farmers

BOD Science (ASX:BOD) signed a supply agreement with licensed cultivator, importer, and genetic holder of medicinal cannabis, Green Farmers, according to a Wednesday release. BOD Science will supply a

MT NewswiresDec 13, 2023 18:32

Bod Science Receives AU$1.6 Million R&D Tax Refund; Shares Rise 8%

Bod Science (ASX:BOD) received a more than AU$1.6 million of research and development tax rebate for fiscal 2023. The rebate fully covers the outstanding AU$1.2 million loan payable to Radium Capital,

MT NewswiresNov 22, 2023 11:02

Bod Expects to Receive Funds From Antah Soon

Bod Science (ASX:BOD) provided an update on its capital raising program, saying it did not secure the AU$440,000 on Nov. 20, because of a delay in the receipt of funds from investor Antah Healthcare G

MT NewswiresNov 21, 2023 21:13

Bod Science Delays Settlement of Tranche 1 of AU$2.1 Million Placement

The settlement of the first tranche of Bod Science's (ASX:BOD) placement to raise AU$2.1 million has been delayed to Nov. 20. The shares were originally expected to be issued on Monday, Nov. 14, the m

MT NewswiresNov 16, 2023 18:21

Bod Science Raises AU$2.1 Million Via Share Placement; Shares Fall 43%

Bod Science (ASX:BOD) raised AU$2.1 million via a two-tranche placement priced at AU$0.03 per share. Proceeds will be used to build the cannabis drug developer's inventory, manufacture products, for w

MT NewswiresNov 8, 2023 11:12

Australian Shares Retreat as Monthly CPI Indicator Rises

Australian shares retreated on Wednesday amid concerns of a longer monetary tightening period as the country's monthly Consumer Price Index indicator rose 5.2% in the 12 months to August. The S&P/ASX

MT NewswiresSep 27, 2023 15:40

Bod Science Validates Greater Bioavailability of Drug Delivery Technology; Shares Rally 12%

Bod Science (ASX:BOD) validated the greater bioavailability of its Aqua Phase drug delivery technology following the results of a recent pharmacokinetic study, the medical cannabis firm said on Wednes

MT NewswiresSep 27, 2023 10:42

Bod Science Completes Acquisition of Drug Delivery Technology; Shares Up 3%

Bod Science (ASX:BOD) completed the acquisition of drug delivery technology Aqua Phase. Aqua Phase has the potential to substantially increase the bioavailability of non-soluble cannabis compounds in

MT NewswiresAug 10, 2023 13:14

Bod Science Validates Bioavailability of Aqua Phase Technology

Bod Science (ASX:BOD) validated a bioavailability capability of its Aqua Phase drug delivery technology following results from a recent pharmacokinetic study, the medical cannabis firm said on Tuesday

MT NewswiresJul 25, 2023 17:39

Bod Science Signs Letter of Intent to Sell Medical Cannabis Products in Malaysia

Bod Science (ASX:BOD) signed a non-binding letter of intent with investment holding firm Antah Group to develop, market, and sell medical cannabis products in Malaysia, according to a Wednesday report.

MT NewswiresJun 21, 2023 14:44

Bod Science Limited (ASX:BOD) Insider Purchases A$16,411.44 in Stock

Bod Science Limited (ASX:BOD – Get Rating) insider David Baker purchased 273,524 shares of the business's stock in a transaction dated Tuesday, March 7th. The shares were purchased at an average cost

Financial News LiveMar 15, 2023 00:36

Non-Executive Chairman David Baker Just Bought A Handful Of Shares In Bod Australia Limited (ASX:BOD)

Yahoo FinanceDec 12, 2022 06:21